Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-07-31
1982-01-12
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260404, 424312, A61K 3122, A61K 3123, C11C 300
Patent
active
043105467
ABSTRACT:
Novel N-(4-acyloxyphenyl)-all-trans-retinamide compounds are useful in preventing epithelial cancer in mammals.
REFERENCES:
patent: 4108880 (1978-08-01), Gander et al.
Goldberg Jerome D.
Johnson & Johnson
Newman Irving
LandOfFree
Novel retinoids and their use in preventing carcinogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel retinoids and their use in preventing carcinogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel retinoids and their use in preventing carcinogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1541227